REBYOTA J Code: J1440

Drug & Product Overview

HCPCS Descriptor Fecal microbiota, live - jslm, 1 ml

HCPCS Added Date July 1, 2023

Manufacturer Ferring Pharmaceuticals

Route of Administration Rectal

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Suspension

About REBYOTA

Rebyota is a medication aligned to the HCPCS J Code: J1440 for billing, pricing, and reimbursement purposes in the United States. This Misc. medication is administered via the rectal route and manufactured by Ferring Pharmaceuticals.

According to CMS Drug Use Information: This product is used to help prevent another return of a certain infection (C. difficile-CDI) in the intestines after completing antibiotics for a return of the infection. This product is made from human stool from screened donors. It is thought to work by giving healthy bacteria to you. Treatment can decrease symptoms of CDI such as diarrhea, nausea, loss of appetite, and stomach tenderness or pain. This product is not used for treatment of CDI.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
55566-9800-02	Rebyota	Ferring Pharmaceuticals Inc.	150	Rebyota Rectal Suspens ion 50000000000 … Login for More
•••••-••••-•• Log in to view	REBYOTA

Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

REBYOTA Pricing & Reimbursement

J1440 Private Payer Reimbursement

$64.58 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

REBYOTA CPT Administration Codes

CPT Code	Description
45300	Proctosigmoidoscopy, rigid; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure).

Not on the CMS JW / JZ list

CMS does not include Rebyota (J1440) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1440. Wastage billing guide →

REBYOTA Medically Unlikely Edits (MUE)

The most billing units of J1440 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 ml.

Practitioner Office & Hospital Outpatient

150 units / day

= 150 ml per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

REBYOTA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Clostridioides difficile infection (CDI) recurrence prevention

Frequently Asked Questions

Is there an available Rebyota billing and coding guide?

Billing and coding information for REBYOTA can be found through FERRING PHARMACEUTICALS, INC.. Visit Here →

Are there any available Rebyota patient assistance programs?

REBYOTA patient assistance information can be found through FERRING PHARMACEUTICALS, INC.. Visit Here →

Where can I find Rebyota prescribing information?

REBYOTA prescribing information can be found at the link below: Visit Here →

Where can I find Rebyota side effect information?

Our team has not yet identified a source of side effects information for REBYOTA. Please check back in a few weeks.

Does billing REBYOTA require JZ/JW wastage modifiers?

CMS does not include REBYOTA (J1440) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1440. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.